Loading...

APC/Cyanine7 anti-human CD45 Antibody

Pricing & Availability
Clone
2D1 (See other available formats)
Regulatory Status
RUO
Other Names
Leukocyte Common Antigen (LCA), T200
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
2D1_APCCy7_CD45_Antibody_FC_102215
Human peripheral blood lymphocytes were stained with CD45 (clone 2D1) APC/Cyanine7 (filled histogram) or mouse IgG1, κ APC/Cyanine7 isotype control (open histogram).
  • 2D1_APCCy7_CD45_Antibody_FC_102215
    Human peripheral blood lymphocytes were stained with CD45 (clone 2D1) APC/Cyanine7 (filled histogram) or mouse IgG1, κ APC/Cyanine7 isotype control (open histogram).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
368515 25 tests 111€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
368516 100 tests 254€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180 - 240 kD single chain type I membrane glycoprotein also known as leukocyte common antigen (LCA) and T200. It is a tyrosine phosphatase expressed on the plasma membrane of all hematopoietic cells, except erythrocytes or platelets. CD45 is a signaling molecule that regulates a variety of cellular processes including cell growth, differentiation, cell cycle, and oncogenic transformation. CD45 plays a critical role in T and B cell antigen receptor-mediated activation by dephosphorylating substrates including p56Lck, p59Fyn, and other Src family kinases. CD45 non-covalently associates with lymphocyte phosphatase-associated phosphoprotein (LPAP) on T and B lymphocytes. CD45 has been reported to bind galectin-1 and to be associated with several other cell surface antigens including CD1, CD2, CD3, and CD4.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Human PBMC
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

It was found that the HI30 clone and the 2D1 clone can cross block each other's binding.

Application References

(PubMed link indicates BioLegend citation)
  1. Bradstock KF, et al. 1980. J. Natl. Cancer Inst. 65:33.
  2. Csiba A, et al. 1984. Br. J. Cancer 50:699.
  3. Tchilian EZ, et al. 2001. J. Immunol. 166:1308.
  4. Lee MS, et al. 2004. Int. Immunol. 16:1109.
Product Citations
  1. Tian L, et al. 2022. Nat Cancer. 3:1318. PubMed
  2. Cai Z, et al. 2023. Adv Sci (Weinh). 10:e2207155. PubMed
  3. Antonyshyn JA, et al. 2022. Biomater Biosyst. 6:100049. PubMed
  4. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
  5. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  6. Healy LM, et al. 2020. Glia. 68:811. PubMed
  7. Ge W, et al. 2022. Int J Mol Sci. 24: . PubMed
  8. Vondra S, et al. 2023. Cell Rep. 42:111977. PubMed
  9. Calvanese V, et al. 2022. Nature. 604:534. PubMed
  10. Wang H, et al. 2022. Front Immunol. 13:852436. PubMed
  11. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  12. Philippeos C, et al. 2018. J Invest Dermatol. 138:811. PubMed
  13. Merugu S, et al. 2020. Methods Enzymol. 639:289. PubMed
  14. Kou R, et al. 2018. Oncol Rep. 7:2013. PubMed
  15. Srideshikan SM, et al. 2019. Clin Cancer Res. 25:7463. PubMed
  16. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  17. Hasselmann J, et al. 2020. Neuron. 103(6):1016-1033. PubMed
  18. Dong Y, et al. 2020. J Leukoc Biol. 108:1711. PubMed
  19. Hazenberg MD, et al. 2019. Blood Adv. 2.659722222. PubMed
  20. Jing Y, et al. 2020. Cancer Gene Ther. 27:910. PubMed
  21. Pandolfi J, et al. 2016. J Immunol. 196: 3287-3296. PubMed
  22. Shi X, et al. 2022. Clin Transl Med. 12:e711. PubMed
  23. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  24. Zhou WJ, et al. 2022. Sci Adv. 8:eabj2488. PubMed
  25. Voskamp C, et al. 2020. Front Bioeng Biotechnol. 0.790277778. PubMed
  26. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  27. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  28. Xi H, et al. 2020. Cell Stem Cell. 27(1):158-176. PubMed
  29. Zhou F, et al. 2018. Cancer Manag Res. 0.727083333. PubMed
  30. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  31. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  32. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  33. Karlsson J, et al. 2020. Nat Commun. 1.773611111. PubMed
  34. Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
  35. Dou D, et al. 2016. Nat Cell Biol. 18: 595-606. PubMed
  36. Antonyshyn JA, et al. 2021. Commun Biol. 4:1205. PubMed
  37. Tan EE, et al. 2020. J Clin Invest. 130:5817. PubMed
RRID
AB_2566375 (BioLegend Cat. No. 368515)
AB_2566375 (BioLegend Cat. No. 368516)

Antigen Details

Structure
Type I transmembrane protein, 180 - 240 kD (multiple isoforms)
Distribution

Hematopoietic cells, except circulating erythrocytes or platelets.

Function
Tyrosine phosphatases, signaling, co-stimulation (co-inhibition), TCR and BCR mediated activation.
Ligand/Receptor
Galectin-1, CD2, CD3, and CD4.
Cell Type
B cells, Dendritic cells, Neutrophils
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Protein Kinases/Phosphatase, TCRs
Antigen References

1. Thomas M. 1989. Annu. Rev. Immunol. 7:339.
2. Trowbridge I, et al. 1994. Annu. Rev. Immunol. 12:85.

Gene ID
5788 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD45 on UniProt.org
Go To Top Version: 1    Revision Date: 10/23/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account